Find any stock by ticker or company name
NCM – Real Time Price. Currency in USD
0.66
-0.02 (-3.29%)
At close: May 12, 2026, 4:00 PM EDT
0.65
-0.00 (-0.53%)
After-hours: May 12, 2026, 7:56 PM EDT
Shuttle Pharmaceuticals Holdings, Inc., a clinical stage pharmaceutical company, develops novel therapies to treat cancers. It owns a pharmaceutical software artificial intelligence (AI) driven platform for molecular discovery and early-stage drug development. The company was founded in 2012 and is headquartered in Gaithersburg, Maryland.
| Name | Position |
|---|---|
| Dr. Milton Brown CSC, M.D., Ph.D. | Co-Founder |
| Dr. Mira Jung Ph.D. | Co-Founder & Chief Scientific Officer for Biology |
| Dr. Tyvin A. Rich M.D. | Chief Clinical Officer & Chief Medical Officer |
| Mr. Christopher Robert Cooper BBA, M.B.A. | Interim CEO & Director |
| Mr. Michael P. Vander Hoek | Vice President for Operations and Regulatory |
| Ms. Yuying Liang B.A., CPA | Chief Financial Officer |
| Date | Type | Document |
|---|---|---|
| 2026-05-07 | 8-K | form8-k.htm |
| 2026-05-01 | 8-K | form8-k.htm |
| 2026-04-20 | DEF 14A | formdef14a.htm |
| 2026-04-10 | PRE 14A | formpre14a.htm |
| 2026-03-31 | 10-K | form10-k.htm |
| 2026-03-10 | 8-K | form8-k.htm |
| 2026-02-17 | 8-K | form8-k.htm |
| 2026-02-13 | CORRESP | filename1.htm |
| 2026-02-11 | S-1/A | forms-1a.htm |
| 2026-02-11 | S-1 | forms-1.htm |